Tilo Biedermann Selected Research

Tilo Biedermann Research Topics

Disease

48	Hypersensitivity (Allergy) 12/2024 - 11/2005
27	Anaphylaxis (Anaphylactic Shock) 01/2024 - 12/2004
20	Atopic Dermatitis (Atopic Eczema) 03/2024 - 11/2002
20	Inflammation (Inflammations) 01/2024 - 11/2002
18	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 01/2003
12	red meat allergy 01/2024 - 01/2016
10	Melanoma (Melanoma, Malignant) 03/2024 - 09/2010
9	Neoplasms (Cancer) 12/2024 - 09/2010
8	Dermatitis 01/2024 - 11/2005
7	Bites and Stings (Sting) 10/2023 - 09/2008
7	Skin Diseases (Skin Disease) 01/2023 - 11/2002
7	Infections 01/2022 - 01/2006
7	Asthma (Bronchial Asthma) 12/2021 - 05/2004
6	COVID-19 12/2024 - 01/2020
5	Food Hypersensitivity (Food Allergy) 01/2024 - 01/2016
5	Tick Bites 01/2024 - 01/2019
5	Exercise-Induced Allergies 10/2023 - 01/2019
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2003
4	Contact Dermatitis (Eczema, Contact) 01/2018 - 04/2012
3	Venom Hypersensitivity 04/2024 - 10/2017
3	Urticaria (Hives) 03/2024 - 07/2011
3	Skin Neoplasms (Skin Cancer) 05/2023 - 05/2020
3	Eczema 01/2023 - 10/2016
3	Seasonal Allergic Rhinitis (Hay Fever) 12/2021 - 01/2020
3	Necrosis 01/2010 - 04/2008
2	Allergic Rhinitis 01/2024 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2008
2	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2010
2	Pruritus (Itching) 12/2021 - 07/2011
2	Mumps 01/2021 - 06/2019
2	Ulcerative Colitis 01/2021 - 09/2020
2	Rubella (German Measles) 01/2021 - 06/2019
2	Measles 01/2021 - 06/2019
2	Carcinoma (Carcinomatosis) 06/2020 - 10/2017
2	Wounds and Injuries (Trauma) 10/2019 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 01/2016
2	Warts (Wart) 06/2019 - 03/2019
2	Acrodermatitis (Gianotti Crosti Syndrome) 07/2018 - 07/2018
2	Carcinogenesis 11/2017 - 10/2017

Drug/Important Bio-Agent (IBA)

21	AllergensIBA 01/2024 - 11/2002
20	Immunoglobulin E (IgE)IBA 01/2024 - 06/2008
11	CytokinesIBA 03/2024 - 01/2003
11	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2006
9	CarbohydratesIBA 01/2024 - 01/2019
8	VaccinesIBA 12/2024 - 08/2012
8	AntibodiesIBA 01/2024 - 07/2011
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
6	Arthropod VenomsIBA 10/2023 - 01/2018
6	EpitopesIBA 01/2022 - 01/2019
5	Interleukin-4 (Interleukin 4)IBA 12/2023 - 01/2003
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2024 - 01/2022
4	Glutens (Glutelin)IBA 03/2024 - 08/2021
4	TabletsIBA 01/2024 - 01/2019
4	Wasp Venoms (Venom, Wasp)IBA 10/2023 - 09/2008
4	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019 - 01/2006
3	Immune Checkpoint InhibitorsIBA 03/2024 - 10/2019
3	AntigensIBA 01/2024 - 01/2016
3	Imiquimod (Aldara)FDA LinkGeneric 07/2023 - 01/2018
3	Interleukin-23 (Interleukin 23)IBA 07/2023 - 10/2011
3	OligosaccharidesIBA 01/2023 - 01/2020
3	COVID-19 VaccinesIBA 01/2023 - 01/2022
3	Galactose (Galactopyranose)FDA LinkGeneric 01/2023 - 01/2019
3	Interleukin-17 (Interleukin 17)IBA 12/2018 - 10/2011
3	Bee Venoms (Bee Venom)IBA 10/2017 - 12/2012
3	LigandsIBA 03/2016 - 03/2012
3	Interleukin-12 (IL 12)IBA 02/2015 - 09/2006
3	Interleukin-10 (Interleukin 10)IBA 07/2014 - 01/2009
3	Peptides (Polypeptides)IBA 01/2014 - 01/2006
2	mRNA VaccinesIBA 12/2024 - 01/2022
2	LipidsIBA 01/2024 - 01/2019
2	AutoantigensIBA 01/2024 - 07/2011
2	Glycoproteins (Glycoprotein)IBA 12/2023 - 01/2022
2	GlycolipidsIBA 12/2023 - 01/2022
2	risankizumabIBA 10/2022 - 10/2022
2	baricitinibIBA 07/2022 - 03/2022
2	ElementsIBA 01/2022 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2016
2	GliadinIBA 08/2021 - 01/2019
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2021 - 06/2019
2	GelatinIBA 01/2021 - 05/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2009
2	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	dupilumabIBA 01/2021 - 11/2019
2	VemurafenibIBA 10/2020 - 01/2013
2	VenomsIBA 01/2020 - 08/2018
2	ORALIT (ORS)IBA 01/2019 - 04/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2011
2	secukinumabIBA 12/2018 - 04/2016
2	ixekizumabIBA 07/2018 - 07/2018
2	Toll-Like Receptor 7IBA 01/2018 - 10/2017
2	HaptensIBA 01/2018 - 04/2012
2	Ustekinumab (CNTO 1275)FDA Link 01/2018 - 10/2011
2	CeramidesIBA 11/2017 - 01/2014

Therapy/Procedure

36	Therapeutics 03/2024 - 01/2003
10	Immunotherapy 12/2024 - 12/2012
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2016
4	Precision Medicine 11/2022 - 10/2016
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Secondary Prevention 06/2020 - 05/2020
2	Radiotherapy 10/2019 - 10/2018